Found 11 vaccines trials

Below is a list of actively recruiting clinical trials based on your search for "vaccines"

18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on adults with non-responsive celiac disease (NRCD) who are on a gluten-free diet. Celiac disease is a condition where eating gluten leads to damage in the small intestine. The study aims to see how the investigational medication affects the small intestine's …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates an investigational vaccine for acne, a common inflammatory skin condition that affects many people worldwide, especially teenagers and young adults. Acne causes pimples, blackheads, and other skin issues. The purpose of this study is to learn about the safety, effectiveness, and the body's immune response to different …
42 days - 89 days
Accepts healthy volunteer
All genders
Phase 3
This study investigates the safety and ability of an investigational pneumococcal vaccine to stimulate the body's defense system in infants. The study compares this investigational vaccine with a licensed pneumococcal vaccine when given alongside routine vaccines to infants aged about 2 months. The investigational vaccine is being tested to see …
42 days - 89 days
Accepts healthy volunteer
All genders
Phase 3
This study investigates the safety of an investigational pneumococcal vaccine compared to a licensed vaccine in infants. The purpose is to understand how the investigational vaccine performs in young children aged 2 to 3 months. Pneumococcal vaccines are used to protect against infections caused by the bacterium Streptococcus pneumoniae, which …
42 days - 89 days
Accepts healthy volunteer
All genders
Phase 3
This study investigates the safety and immune response of an investigational pneumococcal conjugate vaccine in infants. Pneumococcal vaccines are designed to protect against infections caused by the bacteria Streptococcus pneumoniae. The study aims to determine how well the investigational vaccine works in creating antibodies, which are proteins that help fight …
42 days - 112 days
Accepts healthy volunteer
All genders
Phase 3
This study investigates the safety and ability of an investigational pneumococcal conjugate vaccine to stimulate the immune system in infants. The study compares this investigational vaccine with a licensed pneumococcal vaccine. Infants aged approximately 2 months will receive these vaccines alongside routine pediatric vaccines to see how well their bodies …
18 years - 59 years
Accepts healthy volunteer
All genders
Phase 3
This study investigates the safety of an investigational vaccine compared to a licensed vaccine for yellow fever in adults aged 18 to 60 years. Yellow fever is a viral infection transmitted by mosquitoes, which can cause fever, chills, loss of appetite, nausea, muscle pains, and headaches. The study aims to …
60 years or above
Accepts healthy volunteer
All genders
Phase 1/2
This study investigates the safety and immune response to an investigational vaccine designed to prevent lower respiratory tract disease caused by human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) in adults aged 60 years and older. The study aims to understand how well the vaccine works in creating an immune …
7 months - 17 years
Accepts healthy volunteer
All genders
Phase 3
This study investigates the safety and how well the body responds to two different pneumococcal vaccines in infants, toddlers, and children. Pneumococcal vaccines help protect against infections caused by the bacteria Streptococcus pneumoniae, which can lead to illnesses like pneumonia. The study involves comparing an investigational vaccine to an existing …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates the safety and immune response of an investigational vaccine for individuals with mild acne. Acne is a common skin condition characterized by pimples, blackheads, and whiteheads. The study will assess the effects of two doses of the vaccine in adults aged 18 to 45 years.Participants will be …
1 - 10 of 11